Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ioannidou (Thessaloniki, Greece), A. Tychala (Thessaloniki, Greece), E. Faniadou (Thessaloniki, Greece), C. Michailidou (Thessaloniki, Greece), K. Manika (Thessaloniki, Greece), E. Hatziagorou (Thessaloniki, Greece), I. Kioumis (Thessaloniki, Greece). Comparative in vitro activity of fluoroquinolones against P. aeruginosa isolated from Greek CF patients. 686

Member's Comments

No comment yet.

Related content which might interest you: Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment Source: International Congress 2017 – Cystic fibrosis: clinical issues Year: 2017 The role of efflux pump systems and OprD porine in antimicrobial resistance of Pseudomonas aeruginosa strains isolated from patients with bronchiectasis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving P. aeruginosa Source: Eur Respir J 2004; 24: Suppl. 48, 639s Year: 2004 Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes? Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro Source: Eur Respir J 2003; 21: 401-406 Year: 2003 Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006 Molecular genetic characteristics of Pseudomonas aeruginosa strains isolated from children with cystic fibrosis in Moscow. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Acquisition and eradication of P. aeruginosa in young children with CF Source: Breathe 2009; 5: 358 Year: 2009 The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?> Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep? Year: 2017 Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa Source: Eur Respir J, 55 (3) 1802456; 10.1183/13993003.02456-2018 Year: 2020 Proteomic profile of cystic fibrosis sputum cells in adults chronically infected with Pseudomonas aeruginosa Source: Eur Respir J, 50 (1) 1601569; 10.1183/13993003.01569-2016 Year: 2017